Medicover AB (publ) (5M0B.F)
- Previous Close
11.36 - Open
11.08 - Bid 13.60 x --
- Ask 13.96 x --
- Day's Range
11.08 - 13.94 - 52 Week Range
9.99 - 16.40 - Volume
20 - Avg. Volume
22 - Market Cap (intraday)
2.062B - Beta (5Y Monthly) 1.51
- PE Ratio (TTM)
116.17 - EPS (TTM)
0.12 - Earnings Date --
- Forward Dividend & Yield 0.12 (1.06%)
- Ex-Dividend Date Apr 29, 2024
- 1y Target Est
--
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company's Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
www.medicover.com45,316
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 5M0B.F
Performance Overview: 5M0B.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 5M0B.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 5M0B.F
Valuation Measures
Market Cap
2.06B
Enterprise Value
3.06B
Trailing P/E
93.56
Forward P/E
44.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.14
Price/Book (mrq)
4.10
Enterprise Value/Revenue
1.75
Enterprise Value/EBITDA
11.87
Financial Highlights
Profitability and Income Statement
Profit Margin
1.01%
Return on Assets (ttm)
2.06%
Return on Equity (ttm)
3.55%
Revenue (ttm)
1.75B
Net Income Avi to Common (ttm)
17.6M
Diluted EPS (ttm)
0.12
Balance Sheet and Cash Flow
Total Cash (mrq)
62M
Total Debt/Equity (mrq)
189.99%
Levered Free Cash Flow (ttm)
70.71M
Company Insights: 5M0B.F
5M0B.F does not have Company Insights